Quinnova Pharmaceuticals
Exeltis USA Dermatology, Inc. (Formerly Quinnova Pharmaceuticals LLC.) | Rethinking Healthcare
About Quinnova Pharmaceuticals
Quinnova is a specialized company in the pharmaceuticals sector, focusing on the supply of high-quality peptides and supplements aimed at bodybuilding and health optimization. Established in 2007, Quinnova has built a reputation for providing reliable and effective products that cater to both individual consumers and professional athletes. The company operates primarily in the online retail market, offering a wide range of products including MK 677 Ibutamoren, 5 Amino 1MQ, and other specialized supplements. Quinnova's business model revolves around direct-to-consumer sales through its e-commerce platform, ensuring a seamless purchasing experience with detailed product guides, peer-reviewed study insights, and comprehensive customer service. Revenue is generated through product sales, with a focus on repeat customers and subscription models for regular supply. The company also emphasizes privacy and data protection, ensuring customer information is handled with the highest standards of security.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLE✓Equity / VC | Sep 2010 | $300K | — | Undisclosed | — |
| SERIES B✓Equity / VC | Oct 2009 | $17M | $70M | Safeguard Scientifics | — |
Growth signals
Latest recorded traffic for Quinnova Pharmaceuticals is 11K monthly website visits, down 38.9% over the last three months. Quinnova Pharmaceuticals's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Quinnova Pharmaceuticals in the Newtown ecosystem
The Quinnova Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Safeguard Scientifics
Other known investors2 additional known investors
H.I.G. HealthBridge
HIG Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Quinnova Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Quinnova Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









